Medytox Inc. - Sep 8, 2022 Form 4 Insider Report for Evolus, Inc. (EOLS)

Role
10%+ Owner
Signature
/s/ Minjung Choi, Senior Manager, on behalf of Medytox Inc.
Stock symbol
EOLS
Transactions as of
Sep 8, 2022
Transactions value $
-$376,890
Form type
4
Date filed
9/12/2022, 05:45 PM
Previous filing
Aug 3, 2022
Next filing
Sep 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EOLS Common Stock, $0.00001 par value per share Sale -$159K -15.3K -0.21% $10.39 7.42M Sep 8, 2022 Direct F1
transaction EOLS Common Stock, $0.00001 par value per share Sale -$218K -20.7K -0.28% $10.53 7.4M Sep 9, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.34 to $10.50, inclusive. The reporting person undertakes to provide to Evolus, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.45 to $10.70, inclusive.